3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Dermatologic
1
Conditions
Carcinoma, Basal Cell
4
Melanoma
2
Sarcoma, Kaposi
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Carcinoma
1
Interventions
Cisplatin
39
Radiotherapy
21
Carboplatin
21
Cetuximab
20
Paclitaxel
19
Docetaxel
17
Radiotherapy, Intensity-Modulated
15
pembrolizumab
14
Fluorouracil
13
Drug Therapy
10
Nivolumab
8
Radiation
6
cemiplimab
5
atezolizumab
5
Panitumumab
5
Oxaliplatin
5
Erlotinib Hydrochloride
5
Chemoradiotherapy
5
Afatinib
5
Surgical Procedures, Operative
4
durvalumab
3
Surveys and Questionnaires
3
Methotrexate
3
Leucovorin
3
Lapatinib
3
130-nm albumin-bound paclitaxel
3
toripalimab
2
palbociclib
2
osimertinib
2
dacomitinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Carcinoma, Squamous Cell
×
daromun
×
Clear all
NCT05329792
2023-10-06
IntriNSiC
Philogen S.p.A.
Phase 2
Unknown
70 enrolled